Physiological and oncogenic Aurora-A pathway

International Journal of Biological Sciences

Volumn 5, Issue 7, 2009, Pages 758-762

  Saeki, Toshiaki ^a   Ouchi, Mutsuko ^b   Ouchi, Toru ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Aurora A; Cell cycle; Checkpoint; Genome instability; mTOR; Phosphorylation; Plk1

Indexed keywords

AURORA KINASE; BRCA1 PROTEIN; CELL CYCLE PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; ONCOPROTEIN; POLO LIKE KINASE 1; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ANIMAL; CELL TRANSFORMATION; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BRCA1 PROTEIN; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 77449151205     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5.758     Document Type: Review

References (57)

1. Glover G.M., et al. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell, 1995. 81: 95-105.
2. Kimura M., et al. Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast lpl1. J. Bio. Chem., 1997. 272: 13766-13771.
3. Tanaka M., et al. Cell-cycle-dependent regulation of human Aurora A transcription is mediated by periodic repression of E4TF1. J. Biol. Chem., 2002. 277: 10719-10726.
4. Kimura M., et al. Cell-cycle-dependent regulation of the human Aurora B promoter. Biochem. Biophys. Res. Commun., 2004. 316: 930-936.
5. Fu J., et al. Roles of Aurora kinases in mitosis and tumorigene- sis. Mol Cancer Res., 2007. 5: 1-10.
6. Hirota T., et al. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell, 2003. 114: 585-598.
7. Tanaka T., et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res, 1999. 59: 2041-2044.
8. Nishida N., et al. High copy amplification of the Aurora-a gene is associated with chromosomal instability phenotype in hu- man colorectal cancers. Cancer Biol Ther., 2007. 6: 525-533.
9. Compérat E., et al. Aurora-A/STK-15 is a predictive factor for recurrent behavior in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms. Virchows Arch., 2007. 450: 419-424.
10. Li D., et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res., 2003. 9: 991-997.
11. Lassmann S., et al. Predictive value of Aurora-A/STK15 ex- pression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy. Clin Cancer Res., 2007. 13: 4083-4091.
12. Tong T., et al. Overexpression of Aurora-A contributes to ma- lignant development of human esophageal squamous cell car- cinoma. Clin Cancer Res., 2004. 10: 7304-7310.
13. Bischoff J.R., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J., 1998. 17: 3052-3065.
14. Ouchi M., et al. BRCA1 phosphorylation by Aurora-a in the regulation of G2 to M transition. J Biol Chem., 2004. 279: 19643-19648.
15. Okada S, and Ouchi T. Cell cycle differences in DNA dam- age-induced BRCA1 phosphorylation affects its subcellular lo- calization. J Biol Chem., 2003. 278: 2015-2020.
16. Wang X., et al. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene, 2006. 25: 7148-7158.
17. Taga M., et al. Essential Roles of mTOR/Akt Pathway in Aurora-A Cell Transformation. Int J Biol Sci., 2009. 19: 444-450.
18. Marumoto T., et al. Roles of aurora-a kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cell, 2002. 7:1173-1182.
19. Meraldi P., et al. Aurora-A overexpression reveals tetraploidi- zation as a major route to centrosome amplification in p53-/- cells. EMBO J., 2002. 21: 483-492.
20. Anand S., et al. Aurora-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to taxol. Cancer Cell, 2003. 3: 51-62.
21. Xu X., et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell, 1999. 3: 389-395.
22. Hsu L.C, and White R.L. BRCA1 is associated with the centro- some during mitosis. Proc Natl Acad Sci USA, 1998. 95: 2983-12988.
23. Hsu L.C, et al. Identification of a gamma-tubulin-bondong domain of BRCA1. Cancer Res., 2001. 61: 7713-7718.
24. Sankaran S., et al. Aurora-A kinase regulates breast can- cer-associated gene 1 inhibition of centrosome-dependent microtubule nucleation. Cancer Res. 2007. 67: 11186-11194.
25. Chiang G.G., et al. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem., 2005. 280: 25485-25490.
26. Holz M.K, and Blenis J. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J Biol Chem., 2005. 280: 26089-26093.
27. Copp J., et al. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res., 2009. 69: 1821-1827.
28. Jacinto E., et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell, 2006. 127: 125-137.
29. Pearce L.R., et al. Identification of protor as a novel ric- tor-binding component of mTOR complex-2. Biochem J., 2007. 405: 513-522.
30. Sabassov D.D., et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent path- way tha regulates the cytoskeleton. Curr Bio., 2004. 14: 1296-1302.
31. Thedieck K., et al. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS ONE, 2007. 2: 1217.
32. Woo S.Y., et al. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expres- sion and signaling. J Biol Chem., 2007. 282: 25604-25612.
33. Yang Q., et al. Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev., 2006. 20: 2820-2832.
34. Sarbassov D.D., et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science, 2005. 307: 1098-1101.
35. Jacinto E., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol., 2004. 6: 1122-1128.
36. Facchinetti V., et al. The mammalian target of rapamycin com- plex 2 controls folding and stability of Akt and protein kinase C. EMBO J., 2008. 27: 1932-1943.
37. Ikenoue T., et al. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signaling. EMBO J., 2008. 27: 1919-1931.
38. Garcia-Martinez J.M., and Alessi D.R. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J., 2008. 416: 375-385.
39. Rosner M., et al. Functional interaction of mTOR complexes in regulating mammalian cell size and cell cycle. Hum Mol Genet., 2009. 18: 3298-3310.
40. Petronczki M., et al. Polo on the Rise-from mitotic entry to cytokinesis with Plk1. Dev Cell, 2008. 14: 646-659.
41. Barr A.R, and Gergely F. Aurora-A: the maker and breaker of spindle poles. J Cell Sci., 2007. 120: 2987-2996.
42. Wittmann T., et al. TPX2, a novel xenopus MAP involved in spindle pole organization. J Cell Biol., 2000. 149: 1405-1418.
43. Kufer T.A., et al. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol., 2002. 158: 617-623.
44. Eyers P.A., et al. A novel mechanism for activation of the pro- tein kinase Aurora A. Curr Biol., 2003. 13: 691-697.
45. Bayliss R., et al. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol Cell, 2003. 12: 851-862.
46. Zhao Z.S., et al. The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A. Moll Cell, 2005. 20: 237-249.
47. Pugacheva E.N., et al. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell, 2007. 129: 1351-1363.
48. Chan E.H., et al. PLK1 regulates mitotic Aurora A function through βTrCP-dependent degradation of hBora. Chromosoma, 2008. 117: 457-469.
49. Seki A., et al. Plk1- and bTrCP-dependent degradation of Bora controls mitotic progression. J Cell Biol., 2008. 181: 65-78.
50. Macurek L., et al. Polo-like kinase-1 is activated by Aurora A to promote checkpoint recovery. Nature, 2008. 455: 119-123.
51. Seki A., et al. Bora and the kinase Aurora A cooperatively acti- vate the kinase Plk1 and control mitotic entry. Science, 2008 320: 1655-1658.
52. Macurek L, et al. Aurora-A and hBora jointhe game of polo. Cancer Res. 2009. 69: 4555-4558.
53. Scolnick D.M, and Halazonetis T.D. Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature, 2000. 406: 430-435.
54. Yu X., et al. Chfr is required for tumor suppression and Aurora A regulation. Nat Genet., 2005. 37: 401-406.
55. Privette L.M., et al. Loss of CHFR expression in mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint. Neoplasia, 2008. 10: 643-652.
56. Summers M.K., et al. The CHFR mitotic checkpoint protein delays cell cycle progression by excluding cyclin B1 from the nucleus. Oncogene, 2005. 24: 2589-2598.
57. Shtivelman E. Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and check- point protein CHFR. Mol Cancer Res., 2003. 1: 959-969.